Annual Drug Patent Expiration for PROMACTA+KIT
Promacta Kit is a drug marketed by Novartis and included in one NDA. It is available from a single supplier. There are three patents protecting this drug.
The generic ingredients in PROMACTA KIT are eltrombopag olamine. One registered supplier for this compound. Additional details are available on eltrombopag olamine’s profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published on Recently expired patent for the drug Novartis PROMACTA KIT